跳至主要内容
临床试验/NCT06223451
NCT06223451已完成不适用

Evaluation of the Efficacy of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Unilateral Neglect in Patients With Subacute-Chronic Phase After Ischemic Stroke

Ankara City Hospital Bilkent2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2023年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Line Bisection Test

研究概览

简要总结

The aim of this study was to randomize stroke patients with unilateral neglect into 2 groups, active and sham groups, and to examine the effects of active inhibitory repetitive transcranial magnetic stimulation on the reduction of neglect symptoms, functional recovery and independence of these patients in activities of daily living.

详细描述

Patients diagnosed with ischemic stroke at least 1 month ago, with unilateral neglect, receiving inpatient rehabilitation at stroke clinics, and meeting the study criteria for both genders between the ages of 18-80, will be divided into two groups. A total of 22 stroke patients, informed about the applied treatments and potential risks, and providing written consent, will be randomly assigned to receive either active repetitive transcranial magnetic stimulation (rTMS) combined with conventional rehabilitation (Mirror therapy and Visual scanning training) or sham (imitation) repetitive transcranial magnetic stimulation (rTMS) combined with conventional rehabilitation.

The study will include 22 randomly selected patients with neglect, with 11 planned in the intervention group and 11 in the control group. Patients will receive active rTMS or sham rTMS for a total of 10 sessions, each lasting 20 minutes, alongside conventional rehabilitation over a period of 2 weeks. rTMS applications will be conducted once daily before the daily rehabilitation program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First-time ischemic stroke
  • Patients at least 1 month after the stroke
  • To be aged between 18 and 80 years old
  • Presence of unilateral neglect
  • No significant cognitive impairment (MMSE > 24 points)
  • Signing an informed consent form indicating willingness to participate in the study

排除标准

  • Epilepsy, history of seizure
  • Metallic implant in the area of stimulation (cochlear implant, brain pacemaker, drug pump etc.)
  • Presence of cardiac pacemaker
  • Severe general condition disorder or accompanying neurological disease
  • Pregnancy
  • Under 18 years of age and over 80 years of age
  • Visual impairment

结局指标

主要结局

Line Bisection Test

时间窗: Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment

The Line Bisection Test is a rapid measure to detect the presence of unilateral spatial neglect. To complete the test, a pencil mark is placed in the middle of 18 horizontal lines. The test is scored by measuring the deviation from the actual center of the line.

Star Cancellation Test

时间窗: Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment

The star cancellation test, there are 13 letters and 10 short words placed between 52 large and 56 small stars. The patient is required to mark all the small stars using a pencil. To demonstrate how it should be done, two small stars are selected from the central section.Scores are calculated by identifying the ratio of the number of removed small stars/the total number of small stars 100 for each empty half-space on the left and right sides.

次要结局

  • Mini-Mental State Examination(Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment)
  • Brunnstrom Recovery Stage(Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment)
  • Stroke Impact Scale(Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment)
  • Catherine Bergego Scale(Before treatment(initial), two weeks after the beginning of the treatment, four weeks after the beginning of the treatment, six weeks after the beginning of the treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayşenur Mert

Medical doctor

Ankara City Hospital Bilkent

研究点 (2)

Loading locations...

相似试验

Evaluation of the Efficacy of Low-Frequency... | 临床试验